Kona Medical

Issaquah, United States Founded: 2009 • Age: 17 yrs
Provides ultrasound-based renal denervation solutions for hypertension treatment.

About Kona Medical

Kona Medical was a Healthcare company based in Issaquah (United States) founded in 2009 by Michael Gertner. It provides ultrasound-based renal denervation solutions for hypertension treatment. It operates on a B2B model. Kona Medical has raised $73.66 million across 7 funding rounds from investors including SVB, Western Technology Investment and Morningside China. The company has 39 employees. Its chief executive is Michael Gertner. The company is recorded as dissolved. Its focus areas include Medical Devices, Cardiovascular Health and Hypertension Treatment. Its legal entity is KONA MEDICAL INC. Its competitors include ReCor Medical, Ablative Solutions, Brattea, Autonomix and Kalos Medical and 4 more; 8 of its 9 listed competitors have raised funding.

Company details

Kona Medical operates with a B2B model, focusing on providing healthcare solutions, developing medical devices, cardiovascular health, and hypertension treatment. Provides ultrasound-based renal denervation solutions for hypertension treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

  • Headquarters Issaquah, United States
  • Employees 39
  • Founders Michael Gertner
  • Sectors
    Healthcare
  • Website konamedical.com
  • Social Facebook
  • Legal Name Kona Medical Inc
Key Metrics
  • Total Equity Funding
    $73.66M (USD)

    in 7 rounds

  • Latest Funding Round
    $10M (USD), Series D

    Sep 2015

  • Investors
    SVB

    & 6 more

  • Employee Count
    39

Funding Insights of Kona Medical

Kona Medical has successfully raised a total of $73.66M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $73.66M
  • Total Rounds 7
  • Last Round Series D β€” $10M
  • First Round $200,011

    (Apr 2010)

  • Investors Count 7

All 7 funding rounds of Kona Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2015$10MSeries D––
–
Oct 2013$10MSeries D––
Dec 2012$10MSeries C––
May 2012$30MSeries C––
Jun 2011$10.86MSeries B––
–
Jun 2010$2.6MSeries A––
–
Apr 2010$200,011Seed––
–
Valuation history

7 investors in total: 7 institutional.

Investors in Kona Medical

Kona Medical has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Western Technology Investment and Morningside China.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Life science & tech focused VC firm investing in the US
–domainvc.comPrinceton, United States
Venture capital and private equity investment firm
–morgenthaler.comPortola Valley, United States
Venture debt is provided globally across multiple sectors.
1980westerntech.comPortola Valley, United States
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
–ewhealthcare.comNew York, United States
-
–biostar.capital-
VC and private equity investments are made in China-US companies.
–morningside.com.cnShanghai, China
Banking services are provided to innovative companies, investors, and individuals.
1983svb.comSanta Clara, United States
Premium access

Investor details for Kona Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Kona Medical

1 people are tracked at Kona Medical (1 in leadership); the tracked headcount is 39.

NameRoleGroup
Michael Gertner
Founder and Chief Executive OfficerLeadership
Premium access

Complete people profiles for Kona Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Kona Medical

3 dated milestones of Kona Medical across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Kona Medical is founded.
  2. Funding First funding round of $200K.
  3. Funding Latest funding round, Series D, of $10.0M.

Competitors of Kona Medical

Kona Medical has 9 listed competitors in our database, 8 of them funded. They include ReCor Medical, Ablative Solutions, Brattea, Autonomix and Kalos Medical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
recormedical.com2009Palo Alto, United States$15M93
Ultrasound-based renal denervation is applied for hypertension treatment.
ablativesolutions.com2011Kalamazoo, United States$293.24M24
A catheter-based renal denervation system for hypertension treatment is developed.
brattea.com2013Xuhui, China$15.2M–
Developer of a medical device for the treatment of hypertension
autonomix.com2014The Woodlands, United States$8.2M–
Minimally invasive neural monitoring and treatment devices are developed.
kalosmedical.com2015Suwon-si, South Korea––
Developer of medical devices for the treatment of hypertension & other chronic diseases
maya-medical.com2010Campbell, United States$6.92M–
Catheter based ablative technology for renal denervation to treat hypertension
vessixvascular.com2003Laguna Hills, United States$27.7M10
Thermoplasty technology for occlusive peripheral vascular diseases is developed.
verve-medical.com2011Santa Barbara, United States$3.63M–
Renal denervation treatments for hypertension are developed by Verve Medical.
symplesurgical.com2012Menlo Park, United States$3.4M–
Microwave ablation is developed for hypertension treatment.
Premium access

Detailed competitors of Kona Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

10 companies that operate in the same segment as Kona Medical (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
SMT is recognized as a developer of cardiovascular medical devices.
1998Surat, Gujarat, India–USD 106.25 M1,090
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M–255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
2006San Francisco, California, United StatesUSD 109.23 MUSD 747.14 M2,000
Provider of neuroprotection devices for carotid artery disease
2007Sunnyvale, California, United StatesUSD 241.8 M––
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
2007East Peoria, Illinois, United StatesUSD 154.77 M–104
Access catheters for neurovascular stroke treatment are provided.
2015Campbell, California, United StatesUSD 596 M––
Biosensor patches are developed for monitoring multiple body vitals.
2011Campbell, California, United StatesUSD 239.95 M–184
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kona Medical

Premium access

Complete news archive for Kona Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kona Medical

Kona Medical was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Kona Medical is headquartered in Issaquah, United States. It is registered at Issaquah, Washington, United States.

Michael Gertner is the current CEO of Kona Medical. They have also founded this company.

Kona Medical is a funded company, having raised a total of $73.66M across 7 funding rounds to date. The company's 1st funding round was a Seed of $200.01K, raised on Apr 2010.

Kona Medical has 39 employees.

Kona Medical operates with a B2B model, focusing on providing healthcare solutions, developing medical devices, cardiovascular health, and hypertension treatment. Provides ultrasound-based renal denervation solutions for hypertension treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Kona Medical's top competitors include ReCor Medical, Autonomix and Ablative Solutions.

Kona Medical has 7 investors. Key investors include SVB, Western Technology Investment, Morningside China, Domain Associates, and Morgenthaler.

Kona Medical operates through Kona Medical Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available